Latest Breaking News On - Inc tarsus pharmaceuticals - Page 1 : comparemela.com

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAdrienne kempsrTarsus pharmaceuticals incCorporate communicationsTarsus pharmaceuticalsInc tarsus pharmaceuticalsMeibomian gland diseaseMedia contactDavid nakasoneheadInvestor relations

Tarsus Pharmaceuticals (TARS) Added to NASDAQ Biotechnology Index

Tarsus Pharmaceuticals (TARS) Added to NASDAQ Biotechnology Index
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Adrienne kempsrExchange commissionUs food drug administrationCorporate communicationsTarsus pharmaceuticals incBiotechnology index fundWall streetNasdaq stockIndex fundTarsus pharmaceuticalsInc tarsus pharmaceuticalsNew drug applicationDrug administrationMeibomian gland diseaseLooking statementsstatementsTarsu form

Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings

Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesElizabeth yeuDemodex blepharitisblepharitisAdrienne kempsrLisa nijmTarsus pharmaceuticals incDrug administrationAmerican academy of ophthalmologyExchange commissionWorld cornea congressCorporate communicationsAmerican academyChief medical advisorNew drug applicationObservational safety trialLong term safety

Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease

Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDemodex blepharitisblepharitisAdrienne kempsrExchange commissionCorporate communicationsTarsus pharmaceuticals incDrug administrationWall streetMeibomian gland diseaseNew drug applicationChief medical officerDry eye diseaseTarsus pharmaceuticalsInc tarsus pharmaceuticalsMeibomian glandLooking statementsstatements